Raffles Medical Group Ltd
BSL.SI : Singapore Exchange
1.020
+0.99%
Share Price in SGD. As of 26 Jul 17:06:43 SGT
All
Chart
Key stats
- 52-Week HighSGD 1.400
- 52-Week LowSGD 0.965
- Market CapSGD 1.9B
- Avg Volume1.2M
- P/E Ratio (TTM)20.40
- Forward Dividend Yield2.4%
Share Price Performance
BSL.SI | Market
| |
---|---|---|
1 Day | 0.99% | 0.24% |
5 Day | 0.00% | -0.31% |
1 Month | 3.55% | 2.49% |
6 Month | 2.00% | 9.02% |
YTD | -6.42% | 6.08% |
1 Year | -18.40% | 6.50% |
5 Year | 3.03% | 9.82% |
Market Analysis
Consensus Share Price Target
Price Target: $1.135
Source: SGX as of 27 Jul 2024
Analyst Ratings
There is no analyst rating data currently available for Raffles Medical Group Ltd.
Valuation
Price to earnings (P/E) ratio
25.5
25.5
Raffles Medical Group Ltd's current P/E ratio of 25.5x is inline with its historical average P/E ratio of 25.5x.
Price to book (P/B) ratio
1.8
2.3
Raffles Medical Group Ltd's current P/B ratio of 1.8x is lower than its historical average P/B ratio of 2.3x.
Earnings
Earnings Highlights
FY 2023 Results Summary
Revenue: SGD 706.92M
Decreased 14% Year-on-Year
Discontinuance of COVID-19 related activities in FY2023
Net Profit: SGD 90M
Decreased 37% Year-on-Year
Discontinuance of COVID-19 related activities in FY2023
Dividend Per Share: SGD 0.02
Represents 49.4% of the Group PATMI for FY2023
Outlook
The Group sees a growing demand for high-end healthcare services in the region and will continue to explore new business opportunities regionally. The Group remains committed to delivering comprehensive healthcare services in the regions in which we operate.
Sources: Raffles Medical Group Ltd Financial Report
Earnings per share (EPS)
The latest earnings per share is $0.05, which is lower than the earnings per share of $0.08 in 2022.
Financials
Financial Statements
26 Feb 2024 | For period ending 31 Dec 2023 |
31 Jul 2023 | For period ending 30 Jun 2023 |
Annual Reports
03 Apr 2024 | For period ending 31 Dec 2023 |